#8,959 by institutional money · Stock
Bolt Biotherapeutics, Inc. (BOLT)
Institutional ownership from Q3 2026 Form 13F filings
$5.06
−0.78% today
Market closed. Prices as of Nov 20, 6:11 AM ET
- 13F holders
- 23 (+0)
- Held by 13F filers, live
- $2.9M
- Shares held
- 576,383
- Share of stock outstanding
- 22.1%
- Net buying in Q3 2026
- −$102K
- New positions / sold out
- 1 / 1
Largest holders
23 investors| Investor | Shares | Value, live | % of their portfolio | vs Q2 2026 |
|---|---|---|---|---|
| Sofinnova Investments, Inc. | 137,721 | $697K | <0.1% | Unchanged |
| Renaissance Technologies LLC | 92,925 | $470K | <0.1% | Reduced −6% |
| Vivo Capital, LLC | 72,414 | $366K | <0.1% | Unchanged |
| T3 Companies, LLC | 38,000 | $192K | 0.21% | Unchanged |
| Board of Trustees of The Leland Stanford Junior University | 35,977 | $182K | <0.1% | Unchanged |
| Pfizer Inc | 31,305 | $158K | 0.15% | Unchanged |
| Lynx1 Capital Management LP | 30,800 | $156K | <0.1% | Unchanged |
| Nano Cap New Millennium Growth Fund L P | 27,500 | $139K | 0.11% | Unchanged |
| Citadel Advisors LLC Ken Griffin | 18,300 | $93K | <0.1% | Reduced −68% |
| Susquehanna International Group, LLP | 16,838 | $85K | <0.1% | New |
| Shay Capital LLC | 16,526 | $84K | <0.1% | Added +7% |
| Geode Capital Management, LLC | 15,797 | $80K | <0.1% | Reduced −17% |
| Vanguard Fiduciary Trust Co | 15,533 | $79K | <0.1% | Added +402% |
| BlackRock, Inc. | 9,711 | $49K | <0.1% | Unchanged |
| Vanguard Capital Management LLC | 7,060 | $36K | <0.1% | Unchanged |
| Nan Fung Group Holdings Ltd | 5,000 | $25K | <0.1% | Unchanged |
| Morgan Stanley | 4,167 | $21K | <0.1% | Added +32% |
| Tower Research Capital LLC (TRC) | 500 | $3K | <0.1% | Reduced −71% |
| JPMORGAN Chase & Co | 290 | $1K | <0.1% | Added +590% |
| SBI Securities Co., Ltd. | 10 | $51 | <0.1% | Reduced −92% |
| Barclays Plc | 6 | $30 | <0.1% | Unchanged |
| UBS Group AG | 2 | $10 | <0.1% | Reduced −99% |
| Citigroup Inc | 1 | $5 | <0.1% | Reduced −98% |